JanOne stock rises 4.55 percent to EUR 0.46

Published on 10/02/2026 at 17:28 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

JanOne stock stood at EUR 0.46 on October 2, 2026 versus EUR 0.44. Revenue rose 45.40 percent to USD 216.46 million in the second quarter.

JAN, US47089W1045, Illustration mit AI erstellt.

JanOne stock (ISIN US47089W1045) was trading at EUR 0.46 at Lang & Schwarz on October 2, 2026 at 5:10 p.m. CEST, up 4.55 percent versus the prior close of EUR 0.44 on October 1, 2026. The move comes as investors weigh strong revenue growth against a quarterly earnings shortfall and the company's fiscal 2026 outlook.

Revenue growth outpaced estimates

According to MarketBeat on September 12, 2026, revenue in the second quarter of 2026 rose 45.40 percent year over year to USD 216.46 million, exceeding the USD 203.32 million consensus estimate. The increase gives the company a measurable operating-growth argument, but the result was not uniformly positive.

Quarterly earnings per share were USD 0.05, below the USD 0.23 consensus estimate, a shortfall of USD 0.18. MarketBeat also reported that JanOne reaffirmed fiscal 2026 earnings-per-share guidance of USD 0.95 to USD 0.98, while analysts cited in the report expected USD 0.97 for the year.

Opioid treatment remains the mission

JanOne describes its business mission as bringing treatments to market for diseases that cause severe pain and developing non-addictive answers to pain treatment, according to its JanOne website. The company says its approach is designed to reduce the need for opioid prescriptions, linking its biotechnology strategy directly to the opioid crisis.

The latest figures therefore present two distinct signals. Revenue growth of 45.40 percent and sales above consensus point to expanding activity, while earnings per share of USD 0.05 versus USD 0.23 expected highlights the gap between revenue expansion and quarterly profitability.

JanOne stock rises in trading

At Lang & Schwarz, JanOne stock stood at EUR 0.46 on October 2, 2026 at 5:10 p.m. CEST, in trading and up 4.55 percent versus the EUR 0.44 prior close from October 1, 2026. The euro quotation is the reference price for investors in Germany.